CEO Interviews

CEOLIVE Interviews CEO’s & Executives from publicly traded companies and start-ups.

Vuzix $VUZI Taking Augmented Reality By Storm with Award Winning Smart Glasses Technology
16 Nov
2017
Written by Mike Elliott

Vuzix $VUZI Taking Augmented Reality By Storm with Award Winning Smart Glasses Technology »

We are back again with Vuzix, a leading supplier of Smart Glasses, Augmented Reality technologies and products for the consumer and enterprise markets which trades under ticker VUZI.

Read more...
Newgioco Group $NWGI Pursues Multi-Billion Dollar Global Online Gambling Market
13 Nov
2017
Written by Mike Elliott

Newgioco Group $NWGI Pursues Multi-Billion Dollar Global Online Gambling Market »

Newgioco is a leisure betting technology company providing regulated lottery and gaming products and services throughout licensed subsidiaries in Europe. In this interview Mr. Ciavarella discusses the company's operations both here and in Europe as well as their cutting edge technology platform for online betting.

Read more...
Hemispherx $HEB Ramping Up Manufacturing to Pursue Multi-Billion Dollar Immuno-Oncology Market
13 Nov
2017
Written by Mike Elliott

Hemispherx $HEB Ramping Up Manufacturing to Pursue Multi-Billion Dollar Immuno-Oncology Market »

In this episode of CEOLIVE we’re joined by Mr. Thomas Equels, CEO of Hemispherx Biopharma, which trades on the NYSE under ticker HEB. Hemispherx is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders.

Read more...
Citius Pharma $CTXR Receives “Fast Track” Designation By FDA For Potential $500M Product – Mino-Lok™
2 Nov
2017
Written by Mike Elliott

Citius Pharma $CTXR Receives “Fast Track” Designation By FDA For Potential $500M Product – Mino-Lok™ »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases.

Read more...
BioSig’s $BSGM Disruptive Technology Nears Commercialization in $4B EP Market
26 Oct
2017
Written by Mike Elliott

BioSig’s $BSGM Disruptive Technology Nears Commercialization in $4B EP Market »

BioSig Technologies, Inc. is a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace.

Read more...
3D Printing Leader Nano Dimension $NNDM Starts Commercial Sales in U.S.
18 Oct
2017
Written by Mike Elliott

3D Printing Leader Nano Dimension $NNDM Starts Commercial Sales in U.S. »

In this episode of CEOLIVE.TV we are joined again by Amit Dror, CEO of Nano Dimension (NNDM), a leading additive manufacturing company based in Israel. Mr. Dror discusses the first commercial sale of their innovative DragonFly 2020 3D printer to the U.S. based firm, Jabil.

Read more...

Login

Lost your password?